Susan M Stalnecker Leidos Holdings, Inc. (LDOS) insider trading activity

Susan M Stalnecker is Director of Leidos Holdings, Inc.. Currently has a direct ownership of 20,985 shares of LDOS, which is worth approximately $2.66 Million. The most recent transaction as insider was on Feb 18, 2025, when has been sold 8,278 shares (Common Stock) at a price of $132.26 per share, resulting in proceeds of $1,094,848. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21K

34.0% 3M change

42.29% 12M change

Total Value Held $2.66 Million

SUSAN M STALNECKER Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 18 2025	SELL Payment of exercise price or tax liability	$1,094,848 $132.26 p/Share	8,278 Reduced 28.29%	20,985 Common Stock
Feb 18 2025	BUY Exercise of conversion of derivative security	$1,157,615 $85.1 p/Share	13,603 Added 31.73%	29,263 Common Stock
May 03 2024	BUY Grant, award, or other acquisition	-	912 Added 5.5%	15,660 Common Stock
May 02 2024	SELL Open market or private sale	$427,897 $141.97 p/Share	3,014 Reduced 16.97%	14,748 Common Stock
May 02 2024	SELL Payment of exercise price or tax liability	$252,245 $142.19 p/Share	1,774 Reduced 9.08%	17,762 Common Stock
May 02 2024	BUY Exercise of conversion of derivative security	$252,327 $52.7 p/Share	4,788 Added 19.68%	19,536 Common Stock
May 12 2023	SELL Payment of exercise price or tax liability	$206,163 $78.27 p/Share	2,634 Reduced 15.15%	14,748 Common Stock
May 12 2023	BUY Exercise of conversion of derivative security	$206,162 $39.7 p/Share	5,193 Added 23.0%	17,382 Common Stock
May 05 2023	BUY Grant, award, or other acquisition	-	1,574 Added 11.44%	12,189 Common Stock
May 06 2022	BUY Grant, award, or other acquisition	-	1,106 Added 9.44%	10,615 Common Stock
May 07 2021	BUY Grant, award, or other acquisition	-	1,059 Added 10.02%	9,509 Common Stock

Also insider at

BVS

Bioventus Inc. Healthcare

Director

SMS